A single therapeutic tool designed to treat multiple distinct mutations within a gene, making therapy development broadly scalable and patient-inclusive.

Directly targeting the genetic cause of inherited diseases to offer long-lasting, disease-modifying cures, rather than lifelong symptomatic treatments.

Highly specific genome editing designed to only target the mutated gene allele, ensuring preservation of normal gene allele function.

Our platform can be readily adapted to address a broad portfolio of autosomal dominant diseases, maximizing global patient impact.